Top compounds associated with response to ADCY1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.053 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC -0.039 0.3
mRNA tivozanib GDSC1000 pan-cancer AAC -0.027 0.5
mRNA tosedostat CTRPv2 pan-cancer AAC -0.003 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.5
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.058 0.06
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.098 0.02
mRNA triptolide CTRPv2 pan-cancer AAC 0.051 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.06 0.2
Download CSV